Invention Grant
- Patent Title: Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes
-
Application No.: US15076269Application Date: 2016-03-21
-
Publication No.: US09970006B2Publication Date: 2018-05-15
- Inventor: Brian Bettencourt , Kevin Fitzgerald , Stuart Milstein , Martin A. Maier , Klaus Charisse , Kallanthottathil Rajeev , Satyanarayana Kuchimanchi , Muthiah Manoharan , Tuyen Nguyen
- Applicant: Alnylam Pharmaceuticals, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting an APOC3 gene, and methods of using the dsRNA to inhibit expression of APOC3.
Public/Granted literature
- US20160333342A1 Compositions and Methods for Inhibition of Expression of Apolipoprotein C-III (APOC3) Genes Public/Granted day:2016-11-17
Information query
IPC分类:
